Indication intelligence, analysis and sector perception

Dissemination

May 16, 2013 8:39pm

RegMedinvestors, RMi or its afiliate Scimitar delivers reviews, analysis and synthesis of selected segments within the regenerative medicine, stem cell and cell therapy <health/life science industry> via the world-wide web and our proprietary news portal or website to the institutional, advisory and retail investment communities. RMi's <Scimitar> website: www.regmedinvestors.com is accessed via the internet by organizations and individuals resident in different countries in the world.

The information presented on our news portal and web site is provided only as an aid for informing those who make their own investment decisions and are not to be used or considered as an offer to sell or solicitation of an offer to buy any financial products. This site is intended to be accessed by residents of the United States and by residents of other jurisdictions only where permitted by law.

35 companies, 1 interpreter!

Insight, foresight and recommendation

My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.

My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.

Do you have an opinion you would like to share with us? We would like to hear from you.

Please e-mail us at hwm@regmedinvestors.com.

Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors with past experience in sell-side analysis, buy-side management, corporate management and due diligence.

RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.

The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.

The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.